Li-Ping Gong

Li-Ping Gong

Auto-generated profile, based on publicly available information

Li-Ping Gong

Third Affiliated Hospital of Sun Yat-Sen University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2020 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
LGLi‐Ping Gong
Li‐Ping Gong
JCJian-ning Chen
Jian-ning Chen
MDMin Dong
Min Dong
ZXZhen‐Dong Xiao
Zhen‐Dong Xiao
ZFZhi‐Ying Feng
Zhi‐Ying Feng
CSChun-kui Shao
Chun-kui Shao

1 October 2025 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
LGLi-Ping Gong
Li-Ping Gong
YWYulan Weng
Yulan Weng
JZJing Zhou
Jing Zhou
XHXiangqi Huang
Xiangqi Huang
JCJian-Ning Chen
Jian-Ning Chen
CSChun-kui Shao
Chun-kui Shao
Original Article Development and validation of a nomogram comprising GLUT1 and clinical characteristics for predicting overall survival in intrahepatic cholangiocarcinoma Li-Ping Gong, Yulan Weng, Jing Zhou, Xiangqi Huang, Jian-Ning Chen, Dan He, Yi-Wang Zhang, Yongmei Cui, Jing Liang, Chun-Kui Shao

17 April 2025
Verified
Preprint
Open access
LGLi Gong
Li Gong
YWYulan Weng
Yulan Weng
JZJing Zhou
Jing Zhou
XHXiangqi Huang
Xiangqi Huang
JCJianning Chen
Jianning Chen
CSChun-Kui Shao
Chun-Kui Shao
Intrahepatic cholangiocarcinoma (iCCA) is a hepatic malignant tumor that arises from the epithelial cells of the intrahepatic bile ducts and its incidence is increasing worldwide. Patients with iCCA have a poor prognosis because of the aggressiveness of the tumor, delayed diagnosis and lack of effective treatment. Therefore, seeking novel molecular biomarkers and accurate assessment of disease progression are critical to optimize treatment strategies for iCCA. Here, we found that the mRNA levels of SLC2A1 (encoding glucose transporter 1, GLUT1) increased significantly in different types of solid tumor tissues, compared with their adjacent normal tissues, through the TCGA database. By further analysis of the protein expression of GLUT1 in 95 paraffin-embedded iCCA samples by immunohistochemistry, we found that GLUT1 expression was significantly upregulated in tumor tissues compared with adjacent non-tumor tissues. Importantly, high GLUT1 expression was significantly correlated with vascular invasion, advanced T stage, advanced N stage and advanced TNM stage. Survival analysis revealed that iCCA patients with high GLUT1 expression had a worse overall survival. In addition, we established a nomogram which incorporated age, tumor size and GLUT1 expression to estimate the prognosis of iCCA. The nomogram exhibited robust discriminatory ability, accuracy, and clinical usefulness in predicting patients’ overall survival after resection. In conclusion, our study clarified the prognostic value of GLUT1 and provided an effective and accurate prognostic model for evaluating the prognosis of iCCA patients.